450 related articles for article (PubMed ID: 36465301)
21. The role of illicit, licit, and designer drugs in the traffic in Hungary.
Institóris L; Hidvégi E; Dobos A; Sija É; Kereszty ÉM; Tajti LB; Somogyi GP; Varga T
Forensic Sci Int; 2017 Jun; 275():234-241. PubMed ID: 28412575
[TBL] [Abstract][Full Text] [Related]
22. Licit and illicit substance use patterns among university students in Germany using cluster analysis.
Schilling L; Zeeb H; Pischke C; Helmer S; Schmidt-Pokrzywniak A; Reintjes R; Walter U; Girbig M; Krämer A; Icks A; Schneider S
Subst Abuse Treat Prev Policy; 2017 Oct; 12(1):44. PubMed ID: 29058635
[TBL] [Abstract][Full Text] [Related]
23. Non-natural manners of death among users of illicit drugs: Substance findings.
Delaveris GJ; Teige B; Rogde S
Forensic Sci Int; 2014 May; 238():16-21. PubMed ID: 24637034
[TBL] [Abstract][Full Text] [Related]
24. [Acting out and psychoactive substances: alcohol, drugs, illicit substances].
Gillet C; Polard E; Mauduit N; Allain H
Encephale; 2001; 27(4):351-9. PubMed ID: 11686057
[TBL] [Abstract][Full Text] [Related]
25. Prevalence of psychotic symptoms in substance users: a comparison across substances.
Smith MJ; Thirthalli J; Abdallah AB; Murray RM; Cottler LB
Compr Psychiatry; 2009; 50(3):245-50. PubMed ID: 19374969
[TBL] [Abstract][Full Text] [Related]
26. Agreement between self-reported psychoactive substance use and urine toxicology results for adults with opioid use disorder admitted to hospital.
Moreno JL; Duprey MS; Hayes BD; Brooks K; Khalil S; Wakeman SE; Roberts RJ; Jacobson JS; Devlin JW
Toxicol Commun; 2019; 3(1):94-101. PubMed ID: 32051924
[TBL] [Abstract][Full Text] [Related]
27. Problematic khat use as a possible risk factor for harmful use of other psychoactive substances: a mixed method study in Ethiopia.
Mihretu A; Teferra S; Fekadu A
Subst Abuse Treat Prev Policy; 2017 Nov; 12(1):47. PubMed ID: 29096691
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of psychoactive substances, alcohol, illicit drugs, and medicines, in Spanish drivers: a roadside study.
Gómez-Talegón T; Fierro I; González-Luque JC; Colás M; López-Rivadulla M; Javier Álvarez F
Forensic Sci Int; 2012 Nov; 223(1-3):106-13. PubMed ID: 22947432
[TBL] [Abstract][Full Text] [Related]
29. [High-risk drug use: epidemiological pattern through hair testing in the forensic context].
Burgueño MJ; Sánchez S; Castro MÁ; Mateos-Campos R
Rev Esp Salud Publica; 2019 Nov; 93():. PubMed ID: 31767827
[TBL] [Abstract][Full Text] [Related]
30. Substituting cannabis for prescription drugs, alcohol and other substances among medical cannabis patients: The impact of contextual factors.
Lucas P; Walsh Z; Crosby K; Callaway R; Belle-Isle L; Kay R; Capler R; Holtzman S
Drug Alcohol Rev; 2016 May; 35(3):326-33. PubMed ID: 26364922
[TBL] [Abstract][Full Text] [Related]
31. New psychoactive substances in Eurasia: a qualitative study of people who use drugs and harm reduction services in six countries.
Kurcevič E; Lines R
Harm Reduct J; 2020 Nov; 17(1):94. PubMed ID: 33256747
[TBL] [Abstract][Full Text] [Related]
32. An overview of the use of psychoactive substances among students at the University of Lille during the COVID-19 health crisis: Results of the PETRA study.
Carton L; Bastien A; Chérot N; Caron C; Deheul S; Cottencin O; Gautier S; Moreau-Crépeaux S; Dondaine T; Bordet R
Dialogues Clin Neurosci; 2023 Dec; 25(1):101-111. PubMed ID: 37837439
[TBL] [Abstract][Full Text] [Related]
33. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
Napoletano S; Basile G; Lo Faro AF; Negro F
Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
[TBL] [Abstract][Full Text] [Related]
34. Comparison of methadone and high dosage buprenorphine users in French care centres.
Barrau K; Thirion X; Micallef J; Chuniaud-Louche C; Bellemin B; San Marco JL
Addiction; 2001 Oct; 96(10):1433-41. PubMed ID: 11571062
[TBL] [Abstract][Full Text] [Related]
35. Comparison of urine results concerning co-consumption of illicit heroin and other drugs in heroin and methadone maintenance programs.
Musshoff F; Trafkowski J; Lichtermann D; Madea B
Int J Legal Med; 2010 Sep; 124(5):499-503. PubMed ID: 19672612
[TBL] [Abstract][Full Text] [Related]
36. Patterns of polysubstance use and clinical comorbidity among persons seeking substance use treatment: An observational study.
Ellis JD; Rabinowitz JA; Ware OD; Wells J; Dunn KE; Huhn AS
J Subst Use Addict Treat; 2023 Mar; 146():208932. PubMed ID: 36880895
[TBL] [Abstract][Full Text] [Related]
37. Use Of Psychoactive Drugs Among Medical Undergraduates In Abbottabad.
Nawaz H; Khan AA; Bukhari S
J Ayub Med Coll Abbottabad; 2017; 29(4):599-603. PubMed ID: 29330986
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of psychoactive substances in truck drivers in the Nord-Pas-de-Calais region (France).
Labat L; Fontaine B; Delzenne C; Doublet A; Marek MC; Tellier D; Tonneau M; Lhermitte M; Frimat P
Forensic Sci Int; 2008 Jan; 174(2-3):90-4. PubMed ID: 17418990
[TBL] [Abstract][Full Text] [Related]
39. Specificity of genetic and environmental risk factors for symptoms of cannabis, cocaine, alcohol, caffeine, and nicotine dependence.
Kendler KS; Myers J; Prescott CA
Arch Gen Psychiatry; 2007 Nov; 64(11):1313-20. PubMed ID: 17984400
[TBL] [Abstract][Full Text] [Related]
40. Monitoring psychoactive substance use at six European festivals through wastewater and pooled urine analysis.
Bijlsma L; Celma A; Castiglioni S; Salgueiro-González N; Bou-Iserte L; Baz-Lomba JA; Reid MJ; Dias MJ; Lopes A; Matias J; Pastor-Alcañiz L; Radonić J; Turk Sekulic M; Shine T; van Nuijs ALN; Hernandez F; Zuccato E
Sci Total Environ; 2020 Jul; 725():138376. PubMed ID: 32298891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
